These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17576948)

  • 1. The era of targeted therapies: increasing role for novel oncologic drugs in dermatology.
    Montella L; Palmieri G; Lacouture M
    Arch Dermatol; 2007 Jun; 143(6):788-9. PubMed ID: 17576948
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted therapies: a nursing perspective.
    Kay P
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Melanoma: a new therapeutic era].
    Berthod G; Homicsko K; Bouchaab H; Matter M; Cerottini JP; Guggisberg D; Speiser D; Leyvraz S; Michielin O
    Rev Med Suisse; 2011 May; 7(296):1126-30. PubMed ID: 21721201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors.
    Nielsen DL; Andersson M; Kamby C
    Cancer Treat Rev; 2009 Apr; 35(2):121-36. PubMed ID: 19008049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted cancer. These "smart weapons" hit cancer in novel ways.
    Held-Warmkessel J
    Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic targets.
    Farley J; Birrer MJ
    Cancer Treat Res; 2009; 149():63-84. PubMed ID: 19763431
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarker targets and novel therapeutics.
    Clouser M; Hess LM; Chambers SK
    Cancer Treat Res; 2009; 149():85-105. PubMed ID: 19763432
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
    Zhu AX
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular targeted therapies for solid tumors: management of side effects.
    Grünwald V; Soltau J; Ivanyi P; Rentschler J; Reuter C; Drevs J
    Onkologie; 2009 Mar; 32(3):129-38. PubMed ID: 19295254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted anti-cancer therapy in the elderly.
    Gonsalves W; Ganti AK
    Crit Rev Oncol Hematol; 2011 Jun; 78(3):227-42. PubMed ID: 20599391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A; Graeven U
    Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
    [No Abstract]   [Full Text] [Related]  

  • 12. Small molecule inhibitors of tyrosine kinase: waiting for the good news in colorectal cancer as well.
    Sobrero A; Andretta V
    Onkologie; 2008 May; 31(5):224-5. PubMed ID: 18497509
    [No Abstract]   [Full Text] [Related]  

  • 13. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
    Albo D; Farrow B; Berger DH
    Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired resistance to tyrosine kinase inhibitors during cancer therapy.
    Engelman JA; Settleman J
    Curr Opin Genet Dev; 2008 Feb; 18(1):73-9. PubMed ID: 18325754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
    Abasq C; Duval-Modeste AB; Courville P; Joly P
    Ann Dermatol Venereol; 2008; 135(6-7):509-11. PubMed ID: 18598807
    [No Abstract]   [Full Text] [Related]  

  • 17. [New agents for solid tumours].
    Raida M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Eigentler TK
    J Dtsch Dermatol Ges; 2015 Oct; 13(10):1055-6. PubMed ID: 26408485
    [No Abstract]   [Full Text] [Related]  

  • 19. A dose of reality for rational therapies.
    Nat Biotechnol; 2005 Mar; 23(3):267. PubMed ID: 15765066
    [No Abstract]   [Full Text] [Related]  

  • 20. The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl.
    Eck MJ; Manley PW
    Curr Opin Cell Biol; 2009 Apr; 21(2):288-95. PubMed ID: 19217274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.